Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tricilest vs Diane-35 in Acne Vulgaris
NCT00752635Phase 4Completed
- Sponsor
- Johnson & Johnson
- Start
- Sep 2004
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of norgestimate + ethinyl estradiol in acne vulgaris, sponsored by Johnson & Johnson. Started Sep 2004; status: completed.
02
Drugs
norgestimate + ethinyl estradiol
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT00752635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00752635.